Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 13, 2017 Filed Dec 15, 2017 21:18 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
GrantCommon Stock | 1,194.3648 | $52.84 | $63,110.24 |
DisclosureSEC source: 0001209191-17-065911 · doc4.xml · nonDerivative · entry 1 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,409.9527 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 21:17 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 342.7277 | $52.84 | $18,109.73 |
DisclosureSEC source: 0001209191-17-065909 · doc4.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,325.0631 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 21:18 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock Equivalents · Derivative | 135.6774 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-065910 · doc4.xml · derivative · entry 2 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135.6774 Underlying: Common Stock · 135.6774 shares Expires not disclosed F2 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units. F2 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 21:18 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 297.956 | $52.84 | $15,744.00 |
DisclosureSEC source: 0001209191-17-065910 · doc4.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,435.9485 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 21:23 UTC |
Townsend Christopher GPresident, Asia
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 13,106 | $0.00 Strike: $34.33 | $0.00 |
DisclosureSEC source: 0001209191-17-059752 · doc4.xml · derivative · entry 9 Townsend Christopher G · CIK 0001555359 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,216 Underlying: Common Stock · 13,106 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The options became exercisable in three equal installments on February 23, 2017, 2018 and 2019. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 21:23 UTC |
Townsend Christopher GPresident, Asia
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 17,425 | $0.00 Strike: $45.91 | $0.00 |
DisclosureSEC source: 0001209191-17-059752 · doc4.xml · derivative · entry 8 Townsend Christopher G · CIK 0001555359 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,713 Underlying: Common Stock · 17,425 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The options became exercisable in three equal installments on February 24, 2016, 2017 and 2018. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 21:23 UTC |
Townsend Christopher GPresident, Asia
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 25,181 | $0.00 Strike: $45.15 | $0.00 |
DisclosureSEC source: 0001209191-17-059752 · doc4.xml · derivative · entry 7 Townsend Christopher G · CIK 0001555359 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,181 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options became exercisable in three equal installments on February 25, 2015, 2016 and 2017. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 21:23 UTC |
Townsend Christopher GPresident, Asia
|
SaleCommon Stock | 13,106 | $54.20 | $710,345.20 |
DisclosureSEC source: 0001209191-17-059752 · doc4.xml · nonDerivative · entry 6 Townsend Christopher G · CIK 0001555359 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2),(3) and (4) to this Form 4. F4 · price: The shares were sold in multiple transactions at prices $54.061 to $54.325, inclusive. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 21:23 UTC |
Townsend Christopher GPresident, Asia
|
Exercise / conversionCommon Stock | 13,106 | $34.33 | $449,928.98 |
DisclosureSEC source: 0001209191-17-059752 · doc4.xml · nonDerivative · entry 5 Townsend Christopher G · CIK 0001555359 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 21:23 UTC |
Townsend Christopher GPresident, Asia
|
SaleCommon Stock | 17,425 | $54.29 | $945,985.83 |
DisclosureSEC source: 0001209191-17-059752 · doc4.xml · nonDerivative · entry 4 Townsend Christopher G · CIK 0001555359 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2),(3) and (4) to this Form 4. F3 · price: The shares were sold in multiple transactions at prices $54.225 to $54.370, inclusive. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 21:23 UTC |
Townsend Christopher GPresident, Asia
|
Exercise / conversionCommon Stock | 17,425 | $45.91 | $799,981.75 |
DisclosureSEC source: 0001209191-17-059752 · doc4.xml · nonDerivative · entry 3 Townsend Christopher G · CIK 0001555359 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 21:23 UTC |
Townsend Christopher GPresident, Asia
|
SaleCommon Stock | 25,181 | $54.34 | $1,368,411.08 |
DisclosureSEC source: 0001209191-17-059752 · doc4.xml · nonDerivative · entry 2 Townsend Christopher G · CIK 0001555359 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2),(3) and (4) to this Form 4. F2 · price: The shares were sold in multiple transactions at prices $54.131 to $54.490, inclusive. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 21:23 UTC |
Townsend Christopher GPresident, Asia
|
Exercise / conversionCommon Stock | 25,181 | $45.15 | $1,136,922.15 |
DisclosureSEC source: 0001209191-17-059752 · doc4.xml · nonDerivative · entry 1 Townsend Christopher G · CIK 0001555359 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,181 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 21:16 UTC |
Townsend Christopher GPresident, Asia
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 33,071 | $0.00 Strike: $31.15 | $0.00 |
DisclosureSEC source: 0001209191-17-059597 · doc4.xml · derivative · entry 6 Townsend Christopher G · CIK 0001555359 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,071 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options became exercisable in three equal installments on February 26, 2014, 2015 and 2016. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 21:16 UTC |
Townsend Christopher GPresident, Asia
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 49,660 | $0.00 Strike: $27.19 | $0.00 |
DisclosureSEC source: 0001209191-17-059597 · doc4.xml · derivative · entry 5 Townsend Christopher G · CIK 0001555359 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 49,660 shares Expires 2022-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options became exercisable in three equal installments on August 1, 2013, 2014 and 2015. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 21:16 UTC |
Townsend Christopher GPresident, Asia
|
SaleCommon Stock | 33,071 | $54.60 | $1,805,742.74 |
DisclosureSEC source: 0001209191-17-059597 · doc4.xml · nonDerivative · entry 4 Townsend Christopher G · CIK 0001555359 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. F3 · price: The shares were sold in multiple transactions at prices $54.600 to $54.618, inclusive. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 21:16 UTC |
Townsend Christopher GPresident, Asia
|
Exercise / conversionCommon Stock | 33,071 | $31.15 | $1,030,161.65 |
DisclosureSEC source: 0001209191-17-059597 · doc4.xml · nonDerivative · entry 3 Townsend Christopher G · CIK 0001555359 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 21:16 UTC |
Townsend Christopher GPresident, Asia
|
SaleCommon Stock | 49,660 | $54.61 | $2,711,684.30 |
DisclosureSEC source: 0001209191-17-059597 · doc4.xml · nonDerivative · entry 2 Townsend Christopher G · CIK 0001555359 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. F2 · price: The shares were sold in multiple transactions at prices $54.560 to $54.630, inclusive. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 21:16 UTC |
Townsend Christopher GPresident, Asia
|
Exercise / conversionCommon Stock | 49,660 | $27.19 | $1,350,255.40 |
DisclosureSEC source: 0001209191-17-059597 · doc4.xml · nonDerivative · entry 1 Townsend Christopher G · CIK 0001555359 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:22 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock | 720 | $52.14 | $37,540.80 |
DisclosureSEC source: 0001209191-17-055827 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,324.3467 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:23 UTC |
MORRISON DENISE MDirector
|
GrantCommon Stock | 720 | $52.14 | $37,540.80 |
DisclosureSEC source: 0001209191-17-055833 · doc4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,461 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:22 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 720 | $52.14 | $37,540.80 |
DisclosureSEC source: 0001209191-17-055831 · doc4.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,237.6473 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:21 UTC |
Kennard William EDirector
|
GrantCommon Stock | 720 | $52.14 | $37,540.80 |
DisclosureSEC source: 0001209191-17-055824 · doc4.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,813.7932 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:20 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 720 | $52.14 | $37,540.80 |
DisclosureSEC source: 0001209191-17-055822 · doc4.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,265.976 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:19 UTC |
KELLY ALFRED F JRDirector
|
GrantCommon Stock | 720 | $52.14 | $37,540.80 |
DisclosureSEC source: 0001209191-17-055818 · doc4.xml · nonDerivative · entry 1 KELLY ALFRED F JR · CIK 0001209454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,941.3192 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:19 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock Equivalent Units · Derivative | 479.4783 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-055812 · doc4.xml · derivative · entry 2 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 479.4783 Underlying: Common Stock · 479.4783 shares Expires not disclosed F2 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · kind: The Reporting Person acquired these Common Stock Equivalent Units pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. F2 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:19 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 720 | $52.14 | $37,540.80 |
DisclosureSEC source: 0001209191-17-055812 · doc4.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,137.9924 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:18 UTC |
Herzog David LDirector
|
GrantCommon Stock | 720 | $52.14 | $37,540.80 |
DisclosureSEC source: 0001209191-17-055805 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,512 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:17 UTC |
GUTIERREZ CARLOS MDirector
|
GrantCommon Stock | 720 | $52.14 | $37,540.80 |
DisclosureSEC source: 0001209191-17-055798 · doc4.xml · nonDerivative · entry 1 GUTIERREZ CARLOS M · CIK 0001185943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,902 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:16 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 720 | $52.14 | $37,540.80 |
DisclosureSEC source: 0001209191-17-055793 · doc4.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,982.3353 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 20:24 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 192.992 | $48.65 | $9,389.06 |
DisclosureSEC source: 0001209191-17-052974 · doc4.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,517.6473 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. F2 · balance_after: Includes 2,503.1114 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 20:23 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock Equivalent Units · Derivative | 89.6406 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-052971 · doc4.xml · derivative · entry 4 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89.6406 Underlying: Common Stock · 89.6406 shares Expires not disclosed F4 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F5 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units. F4 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 20:23 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock | 369.6338 | $48.65 | $17,982.68 |
DisclosureSEC source: 0001209191-17-052971 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,604.3467 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. F2 · balance_after: Includes 4,794.1599 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 20:22 UTC |
Kennard William EDirector
|
GrantCommon Stock | 106.7792 | $48.65 | $5,194.81 |
DisclosureSEC source: 0001209191-17-052968 · doc4.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,093.7932 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. F2 · balance_after: Includes 1,384.9283 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 20:21 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 69.6919 | $48.65 | $3,390.51 |
DisclosureSEC source: 0001209191-17-052966 · doc4.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,545.976 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. F2 · balance_after: Includes 903.9065 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 20:20 UTC |
KELLY ALFRED F JRDirector
|
GrantCommon Stock | 237.3359 | $48.65 | $11,546.39 |
DisclosureSEC source: 0001209191-17-052965 · doc4.xml · nonDerivative · entry 1 KELLY ALFRED F JR · CIK 0001209454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,221.3192 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. F2 · balance_after: Includes 3,078.2531 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 20:19 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock Equivalents · Derivative | 142.2508 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-052963 · doc4.xml · derivative · entry 3 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142.2508 Underlying: Common Stock · 142.2508 shares Expires not disclosed F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units. F3 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 20:19 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 315.1069 | $48.65 | $15,329.95 |
DisclosureSEC source: 0001209191-17-052963 · doc4.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,417.9924 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. F2 · balance_after: Includes 4,086.9453 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 20:18 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 363.3381 | $48.65 | $17,676.40 |
DisclosureSEC source: 0001209191-17-052961 · doc4.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,262.3353 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. F2 · balance_after: Includes 4,712.5043 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 20:17 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
GrantCommon Stock | 1,286.6511 | $48.65 | $62,595.58 |
DisclosureSEC source: 0001209191-17-052959 · doc4.xml · nonDerivative · entry 1 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,215.5879 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. F2 · balance_after: Includes 16,687.8966 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 20:18 UTC |
Morris Maria REVP, Global Employee Benefits
|
GrantCommon Stock | 322.6171 | $48.65 | $15,695.32 |
DisclosureSEC source: 0001209191-17-052960 · doc4.xml · nonDerivative · entry 1 Morris Maria R · CIK 0001423154 · EVP, Global Employee Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,278.9192 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral accounts pursuant to the MetLife Deferred Compensation Plan for Officers and the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. F2 · balance_after: Includes 4,184.3515 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 20:18 UTC |
TADROS RAMYEVP & Chief Risk Officer
|
GrantRestricted Stock Units · Derivative | 34,377 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-052591 · doc4.xml · derivative · entry 1 TADROS RAMY · CIK 0001714199 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,377 Underlying: Common Stock · 34,377 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F2 · derivative.exercise_date: The award of Restricted Stock Units will "cliff vest" on September 11, 2020 and will be payable 100% in shares. F2 · derivative.expiration_date: The award of Restricted Stock Units will "cliff vest" on September 11, 2020 and will be payable 100% in shares. Read SEC document |
| August 07, 2017 Filed Sep 15, 2017 20:23 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock Equivalent Units · Derivative | 1,162.642 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-052971 · doc4.xml · derivative · entry 3 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,162.642 Underlying: Common Stock · 1,162.642 shares Expires not disclosed F4 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F5 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units. F4 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F6 · balance_after: Common Stock Equivalents previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Common Stock Equivalents in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Common Stock Equivalents. Read SEC document |
| August 07, 2017 Filed Sep 15, 2017 20:19 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock Equivalents · Derivative | 1,844.9973 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-052963 · doc4.xml · derivative · entry 2 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,844.9973 Underlying: Common Stock · 1,844.9973 shares Expires not disclosed F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units. F3 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F5 · balance_after: Common Stock Equivalents previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Common Stock Equivalents in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Common Stock Equivalents. Read SEC document |
| July 10, 2017 Filed Jul 11, 2017 20:18 UTC |
PODLOGAR SUSAN MEVP & Chief HR Officer
|
GrantRestricted Stock Units · Derivative | 26,762 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-044772 · doc4.xml · derivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,762 Underlying: Common Stock · 26,762 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F2 · derivative.exercise_date: The award of Restricted Stock Units will "cliff vest" on July 10, 2020 and will be payable 100% in shares. F2 · derivative.expiration_date: The award of Restricted Stock Units will "cliff vest" on July 10, 2020 and will be payable 100% in shares. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:22 UTC |
Kennard William EDirector
|
GrantCommon Stock | 704 | $53.31 | $37,530.24 |
DisclosureSEC source: 0001209191-17-040137 · doc4.xml · nonDerivative · entry 2 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,602.0857 F2 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:22 UTC |
Kennard William EDirector
|
GrantCommon Stock | 81.1624 | $53.31 | $4,326.77 |
DisclosureSEC source: 0001209191-17-040137 · doc4.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,898.0857 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:21 UTC |
KELLY ALFRED F JRDirector
|
GrantCommon Stock | 704 | $53.31 | $37,530.24 |
DisclosureSEC source: 0001209191-17-040132 · doc4.xml · nonDerivative · entry 2 KELLY ALFRED F JR · CIK 0001209454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,905.7302 F2 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:21 UTC |
KELLY ALFRED F JRDirector
|
GrantCommon Stock | 192.6251 | $53.31 | $10,268.84 |
DisclosureSEC source: 0001209191-17-040132 · doc4.xml · nonDerivative · entry 1 KELLY ALFRED F JR · CIK 0001209454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,201.7302 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:26 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
GrantCommon Stock | 1,041.1546 | $53.31 | $55,503.95 |
DisclosureSEC source: 0001209191-17-040146 · doc4.xml · nonDerivative · entry 1 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,241.0402 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. F2 · balance_after: Includes 51,000 shares previously reported as indirectly beneficially owned through a Grantor Retained Annuity Trust ("GRAT"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.